Align Technology | ALGN - Interest Expense On Debt


Align Technology reported $2M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.





Interest Expense On Debt Change Date
3M USD 232M 5M Sep/2025
Align Technology USD 2M 660K Mar/2023
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Bruker USD 20M 4.3M Sep/2025
Cardinal Health USD 88M 8M Dec/2025
Charles River Laboratories USD 23.78M 1.63M Dec/2025
Cooper Companies USD 24.4M 1000K Sep/2025
CVS Health USD 787M 3M Dec/2025
Danaher USD 55M 12M Dec/2025
Dentsply International USD 23M 1000K Sep/2025
Dexcom USD 4.7M 0 Sep/2025
Henry Schein USD 38M 0 Sep/2025
Idexx Laboratories USD 10.08M 1.24M Sep/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 22.72M 1.68M Sep/2025
IQVIA Holdings USD 193M 4M Dec/2025
Masimo USD 8.8M 600K Sep/2025
McKesson USD 63M 11M Dec/2025
Mettler Toledo International USD 17.39M 307K Dec/2025
Revvity USD 23.51M 742K Dec/2025
Solventum Corp USD 13.97B 13.87B Sep/2025
Stryker USD 157M 46.17B Sep/2025
Teleflex USD 31.84M 10.13M Sep/2025
Thermo Fisher Scientific USD 365M 18M Dec/2025
Veeva Systems USD 65.1M 8.4M Mar/2025
Waters USD 8.62M 18.02M Dec/2025
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025
Zoetis USD 57M 1000K Dec/2025